Literature DB >> 15882240

Long-term use of acid suppression started inappropriately during hospitalization.

D A Zink1, M Pohlman, M Barnes, M E Cannon.   

Abstract

BACKGROUND: Practitioners routinely misuse acid suppression medications on general medical floors and inappropriately continue the drug at discharge. AIMS: To: (i) retrospectively study the appropriateness of acid suppression use on the general medical floors; (ii) characterize the patient population discharged on unnecessary acid suppression and (iii) evaluate whether patients discharged on unnecessary acid suppression continue the medicine long term.
METHODS: Retrospective chart review of general medical patients admitted to an in-patient teaching service over 6 consecutive months.
RESULTS: About 60% of patients lacked an indication for initiation of acid suppression and 34% of these patients were discharged on the medicine. The only independent predictor of continuation of acid suppression at discharge was longer length of stay. Multivariate analysis did not identify a characteristic distinguishing those patients discharged inappropriately on acid suppression. At 3 and 6 months of follow-up, 80% and 50% of patients, respectively, remained on acid suppression therapy without an appropriate indication.
CONCLUSIONS: Our data verifies that practitioners routinely start general medical in-patients on acid suppression without an appropriate indication. Many of these prescriptions are continued at discharge for no apparent reason, leading to their long-term misuse.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15882240     DOI: 10.1111/j.1365-2036.2005.02454.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  48 in total

1.  Proton pump inhibitors for prophylaxis of nosocomial upper gastrointestinal tract bleeding: effect of standardized guidelines on prescribing practice.

Authors:  Patrick S Yachimski; Elizabeth A Farrell; Daniel P Hunt; Andrea E Reid
Journal:  Arch Intern Med       Date:  2010-05-10

2.  Overutilization of proton-pump inhibitors: what the clinician needs to know.

Authors:  Joel J Heidelbaugh; Andrea H Kim; Robert Chang; Paul C Walker
Journal:  Therap Adv Gastroenterol       Date:  2012-07       Impact factor: 4.409

3.  Factors associated with the initiation of proton pump inhibitors in corticosteroid users.

Authors:  Jeffrey C Munson; Peter M Wahl; Gregory Daniel; Stephen E Kimmel; Sean Hennessy
Journal:  Pharmacoepidemiol Drug Saf       Date:  2012-01-25       Impact factor: 2.890

Review 4.  Pharmacologic options in the management of upper gastrointestinal bleeding: focus on the elderly.

Authors:  Moe Htet Kyaw; Francis Ka Leung Chan
Journal:  Drugs Aging       Date:  2014-05       Impact factor: 3.923

5.  Stress ulcer prophylaxis in the intensive care unit.

Authors:  Ladan Mohebbi; Kristen Hesch
Journal:  Proc (Bayl Univ Med Cent)       Date:  2009-10

6.  Interventions to curb the overuse of Acid-suppressive medications on an inpatient general medicine service.

Authors:  Randolph E Regal; Amanda D Osta; Vikas I Parekh
Journal:  P T       Date:  2010-02

7.  Proton pump inhibitors and the risk of acute kidney injury in older patients: a population-based cohort study.

Authors:  Tony Antoniou; Erin M Macdonald; Simon Hollands; Tara Gomes; Muhammad M Mamdani; Amit X Garg; J Michael Paterson; David N Juurlink
Journal:  CMAJ Open       Date:  2015-04-02

8.  Intravenous pantoprazole utilization in a level 1 trauma center.

Authors:  David A Edelman; Krupa R Patel; James G Tyburski; Lisa G Hall Zimmerman
Journal:  Surg Endosc       Date:  2007-08-21       Impact factor: 4.584

9.  Proton Pump Inhibitor Use and Risk of Developing Alzheimer's Disease or Vascular Dementia: A Case-Control Analysis.

Authors:  Patrick Imfeld; Michael Bodmer; Susan S Jick; Christoph R Meier
Journal:  Drug Saf       Date:  2018-12       Impact factor: 5.606

10.  Appropriateness of treatment recommendations for PPI in hospital discharge letters.

Authors:  Dirk Ahrens; Jean-François Chenot; Gesa Behrens; Thomas Grimmsmann; Michael M Kochen
Journal:  Eur J Clin Pharmacol       Date:  2010-08-06       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.